The use of the scientific method as dogma can be an obstacle in times of pandemic

Autores
Inserra, Felipe; Manucha, Walter Ariel Fernando; Ferder, Leon Fernando
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Under pandemic circumstances, the scientific method used as a dogma does not contribute to the humanitarian help that this critical moment deserves.Researchers and developers made a terrific job giving us the desired protection. More than 90 % of effectivity is a standard of high quality of the vaccine. We are ready to use it, but health authorities around the world must give us the possibilities to protect our lives. They must stop with dilatory behavior and permit us the adequate use of vaccines against coronavirus immediately. We are waiting that science and health authorities may assume their remarkably high responsibility.
Fil: Inserra, Felipe. Universidad de Maimónides; Argentina
Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad del Aconcagua. Facultad de Ciencias Médicas; Argentina
Fil: Ferder, Leon Fernando. Universidad de Maimónides; Argentina
Materia
VACCINE
COVID-19
PUBLIC HEALTH
PANDEMIC
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/149784
Acceder
id CONICETDig_eab8f7ba0cf6a0760535d1e80aea9e39
oai_identifier_str oai:ri.conicet.gov.ar:11336/149784
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The use of the scientific method as dogma can be an obstacle in times of pandemicInserra, FelipeManucha, Walter Ariel FernandoFerder, Leon FernandoVACCINECOVID-19PUBLIC HEALTHPANDEMIChttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Under pandemic circumstances, the scientific method used as a dogma does not contribute to the humanitarian help that this critical moment deserves.Researchers and developers made a terrific job giving us the desired protection. More than 90 % of effectivity is a standard of high quality of the vaccine. We are ready to use it, but health authorities around the world must give us the possibilities to protect our lives. They must stop with dilatory behavior and permit us the adequate use of vaccines against coronavirus immediately. We are waiting that science and health authorities may assume their remarkably high responsibility.Fil: Inserra, Felipe. Universidad de Maimónides; ArgentinaFil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad del Aconcagua. Facultad de Ciencias Médicas; ArgentinaFil: Ferder, Leon Fernando. Universidad de Maimónides; ArgentinaHeighten Science Publications2021-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/149784Inserra, Felipe; Manucha, Walter Ariel Fernando; Ferder, Leon Fernando; The use of the scientific method as dogma can be an obstacle in times of pandemic; Heighten Science Publications; Insights in Clinical and Cellular Immunology; 5; 1-2021; 1-22640-2793CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.29328/journal.icci.1001016info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:43:37Zoai:ri.conicet.gov.ar:11336/149784instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:43:38.026CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The use of the scientific method as dogma can be an obstacle in times of pandemic
title The use of the scientific method as dogma can be an obstacle in times of pandemic
spellingShingle The use of the scientific method as dogma can be an obstacle in times of pandemic
Inserra, Felipe
VACCINE
COVID-19
PUBLIC HEALTH
PANDEMIC
title_short The use of the scientific method as dogma can be an obstacle in times of pandemic
title_full The use of the scientific method as dogma can be an obstacle in times of pandemic
title_fullStr The use of the scientific method as dogma can be an obstacle in times of pandemic
title_full_unstemmed The use of the scientific method as dogma can be an obstacle in times of pandemic
title_sort The use of the scientific method as dogma can be an obstacle in times of pandemic
dc.creator.none.fl_str_mv Inserra, Felipe
Manucha, Walter Ariel Fernando
Ferder, Leon Fernando
author Inserra, Felipe
author_facet Inserra, Felipe
Manucha, Walter Ariel Fernando
Ferder, Leon Fernando
author_role author
author2 Manucha, Walter Ariel Fernando
Ferder, Leon Fernando
author2_role author
author
dc.subject.none.fl_str_mv VACCINE
COVID-19
PUBLIC HEALTH
PANDEMIC
topic VACCINE
COVID-19
PUBLIC HEALTH
PANDEMIC
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.4
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Under pandemic circumstances, the scientific method used as a dogma does not contribute to the humanitarian help that this critical moment deserves.Researchers and developers made a terrific job giving us the desired protection. More than 90 % of effectivity is a standard of high quality of the vaccine. We are ready to use it, but health authorities around the world must give us the possibilities to protect our lives. They must stop with dilatory behavior and permit us the adequate use of vaccines against coronavirus immediately. We are waiting that science and health authorities may assume their remarkably high responsibility.
Fil: Inserra, Felipe. Universidad de Maimónides; Argentina
Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad del Aconcagua. Facultad de Ciencias Médicas; Argentina
Fil: Ferder, Leon Fernando. Universidad de Maimónides; Argentina
description Under pandemic circumstances, the scientific method used as a dogma does not contribute to the humanitarian help that this critical moment deserves.Researchers and developers made a terrific job giving us the desired protection. More than 90 % of effectivity is a standard of high quality of the vaccine. We are ready to use it, but health authorities around the world must give us the possibilities to protect our lives. They must stop with dilatory behavior and permit us the adequate use of vaccines against coronavirus immediately. We are waiting that science and health authorities may assume their remarkably high responsibility.
publishDate 2021
dc.date.none.fl_str_mv 2021-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/149784
Inserra, Felipe; Manucha, Walter Ariel Fernando; Ferder, Leon Fernando; The use of the scientific method as dogma can be an obstacle in times of pandemic; Heighten Science Publications; Insights in Clinical and Cellular Immunology; 5; 1-2021; 1-2
2640-2793
CONICET Digital
CONICET
url http://hdl.handle.net/11336/149784
identifier_str_mv Inserra, Felipe; Manucha, Walter Ariel Fernando; Ferder, Leon Fernando; The use of the scientific method as dogma can be an obstacle in times of pandemic; Heighten Science Publications; Insights in Clinical and Cellular Immunology; 5; 1-2021; 1-2
2640-2793
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.29328/journal.icci.1001016
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Heighten Science Publications
publisher.none.fl_str_mv Heighten Science Publications
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268614636339200
score 13.13397

Publicaciones similares